Petlife Pharmaceuticals, Inc.
PTLF
$0.0001
$0.000.00%
| 02/28/2018 | 11/30/2017 | 08/31/2017 | 05/31/2017 | 02/28/2017 | |
|---|---|---|---|---|---|
| Net Income | -427.10K | -466.70K | -2.00M | -815.00K | -1.33M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 63.10K | 77.00K | -78.80K | 37.50K | 50.00K |
| Total Other Non-Cash Items | 202.60K | 262.20K | 1.83M | 630.70K | 1.81M |
| Change in Net Operating Assets | -1.10K | 7.50K | 363.00K | 53.00K | -691.00K |
| Cash from Operations | -162.50K | -119.90K | 114.30K | -93.80K | -156.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 135.00K | 135.00K | -55.30K | 123.50K | 128.30K |
| Total Debt Repaid | -19.00K | -15.00K | -5.00K | -29.80K | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 116.00K | 120.00K | -60.30K | 93.70K | 128.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.50K | 100.00 | 53.90K | -100.00 | -28.60K |
